Free Trial

Moolec Science Q1 2024 Earnings Report

Moolec Science logo
$0.85 -0.01 (-1.68%)
(As of 12/20/2024 05:31 PM ET)

Moolec Science EPS Results

Actual EPS
-$0.04
Consensus EPS
-$0.05
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Moolec Science Revenue Results

Actual Revenue
$1.74 million
Expected Revenue
$0.63 million
Beat/Miss
Beat by +$1.11 million
YoY Revenue Growth
N/A

Moolec Science Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>

Moolec Science Earnings Headlines

We recommended Palantir in 2021, now we’re recommending this...
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
Moolec Science (MLEC) Q4 2024 Earnings Call Transcript
See More Moolec Science Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Moolec Science? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Moolec Science and other key companies, straight to your email.

About Moolec Science

Moolec Science (NASDAQ:MLEC), a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

View Moolec Science Profile

More Earnings Resources from MarketBeat

Upcoming Earnings